Perrigo Company plc

Symbol: PRGO     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
1.65%
Current Price
$51.01
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2018

Update: 2019-06-10 15:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
1,195,200,000
1,195,200,000
752,200,000
443,000,000
336,800,000
106,200,000
81,400,000
2,902,200,000
10,983,400,000
5,315,300,000
5,668,000,000
551,100,000
190,200,000
551,100,000
3,242,400,000
113,900,000
194,300,000
 
44,600,000

Q 3

2018-09-30
1,133,100,000
1,133,100,000
708,300,000
424,800,000
307,000,000
117,800,000
-67,500,000
2,768,800,000
10,942,900,000
5,282,900,000
5,659,800,000
444,200,000
194,200,000
444,200,000
3,265,200,000
-82,900,000
144,000,000
 
43,700,000

Q 2

2018-06-30
1,186,400,000
1,186,400,000
715,400,000
471,000,000
370,900,000
100,100,000
36,200,000
2,778,500,000
11,225,600,000
5,328,300,000
5,897,100,000
526,500,000
197,700,000
526,500,000
3,283,000,000
-144,400,000
82,300,000
 
91,900,000

Q 1

2018-03-31
1,217,000,000
1,217,000,000
724,300,000
492,700,000
334,900,000
157,800,000
80,800,000
2,900,700,000
11,639,600,000
5,434,000,000
6,205,400,000
687,300,000
58,000,000
687,300,000
3,338,600,000
7,700,000
172,400,000
 
38,400,000

Financials 2017

Update: 2019-06-10 15:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
1,283,100,000
1,283,100,000
770,300,000
512,800,000
347,800,000
165,000,000
73,200,000
2,819,600,000
11,628,800,000
5,458,200,000
6,170,500,000
678,700,000
70,400,000
678,700,000
3,341,200,000
-100,800,000
216,900,000
 
46,900,000